Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts.

[1]  Mark Freed,et al.  The Manual of Interventional Cardiology , 2001 .

[2]  E. Ohman,et al.  Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts. , 2000, American heart journal.

[3]  G. Stone,et al.  Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. , 1999, Circulation.

[4]  D. Holmes,et al.  The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. , 1999, Journal of the American College of Cardiology.

[5]  P. Teirstein,et al.  Retrieval and analysis of particulate debris after saphenous vein graft intervention. , 1999, Journal of the American College of Cardiology.

[6]  M. Le May,et al.  Predictors of long-term outcome after stent implantation in a saphenous vein graft. , 1999, The American journal of cardiology.

[7]  F. Matar,et al.  Adjunctive abciximab improves outcomes during recanalization of totally occluded saphenous vein grafts using transluminal extraction atherectomy , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  D. Baim,et al.  Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. , 1998, Journal of the American College of Cardiology.

[9]  J. M. Bloom Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. , 1998, The New England journal of medicine.

[10]  M. Leon,et al.  Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience. , 1997, The American journal of cardiology.

[11]  W. O’Neill,et al.  Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry. , 1997, American Journal of Cardiology.

[12]  R. Califf,et al.  Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. , 1997, The American journal of cardiology.

[13]  E. Topol,et al.  Late myocardial ischemic events after saphenous vein graft intervention--importance of initially "nonsignificant" vein graft lesions. , 1997, The American journal of cardiology.

[14]  E. Jones,et al.  Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. , 1997, Circulation.

[15]  J. O’Keefe,et al.  Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. , 1996, Journal of the American College of Cardiology.

[16]  D. Baim,et al.  Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. , 1996, Journal of the American College of Cardiology.

[17]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[18]  P. Serruys,et al.  Long-term clinical outcome after stent implantation in saphenous vein grafts. , 1996, Journal of the American College of Cardiology.

[19]  E. Jones,et al.  In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. , 1995, Circulation.

[20]  W. O’Neill,et al.  Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. , 1995, Journal of the American College of Cardiology.

[21]  B. Chaitman,et al.  Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. , 1995, Journal of the American College of Cardiology.

[22]  S. Yusuf,et al.  Effect of coronary artery bypass graft surgery on survival , 1994, The Lancet.

[23]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[24]  B. Strauss,et al.  Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. , 1994, The American journal of cardiology.

[25]  D. Baim,et al.  Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. , 1994, Journal of the American College of Cardiology.

[26]  E. Jones,et al.  Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. , 1994, The American journal of cardiology.

[27]  R D Safian,et al.  Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. , 1994, Circulation.

[28]  W. O’Neill,et al.  Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries. , 1993, Circulation.

[29]  E. Topol,et al.  Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. , 1993, Journal of the American College of Cardiology.

[30]  M. Leon,et al.  Excimer Laser Coronary Angioplasty of Aorto‐Ostial Stenoses Results of the Excimer Laser Coronary Angioplasty (ELCA) Registry in the First 200 Patients , 1992, The American journal of cardiology.

[31]  W. Keon,et al.  Coronary bypass graft fate: long-term angiographic study. , 1991, Journal of the American College of Cardiology.

[32]  R D Safian,et al.  Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. , 1990, Circulation.

[33]  W. Keon,et al.  Coronary bypass graft fate. Angiographic study of 1,179 vein grafts early, one year, and five years after operation. , 1986, The Journal of thoracic and cardiovascular surgery.

[34]  F. Burkart,et al.  Coronary artery bypass grafts. Influence of preoperative risk factors on the late postoperative course. , 1985, Chest.